Regeneron's 'Champion Of Cancer Vaccines' Forges New Path

An Interview With Raquel Deering, Associate Director Of Immuno-Oncology At Regeneron

Raquel Deering, one of In Vivo's 2020 Rising Leaders, discusses Regeneron's efforts to develop combination therapies, its collaborations with cancer vaccine companies, and its plans to become a major force in the oncology field.

Magnifying lens over background with text Immuno-oncology, with the blurred lights visible in the background. 3D rendering.
• Source: Shutterstock

More from C-Suite Speaks

More from Leadership